武汉市第八医院妇产科 湖北 武汉 430012
赵丽娟,女,1978—,副主任医师,主要从事妇科肿瘤研究, E‑mail:1036250186@qq.com
陈煌,男,1993—,医学硕士,主治医师,主要从事妇科肿瘤、肿瘤免疫等相关研究, E‑mail:18120564585@163.com
收稿:2024-04-28,
纸质出版:2025-11-25
移动端阅览
赵丽娟,刘晓丽,陈芳等.脂质代谢基因表达对子宫内膜癌免疫微环境及预后的影响[J].武汉大学学报(医学版),2025,46(11):1422-1428.
ZHAO Lijuan,LIU Xiaoli,CHEN Fang,et al.Effect of lipid metabolism genes expression on immunemicro environment and prognosis in endometrial carcinoma[J].Medical Journal of Wuhan University,2025,46(11):1422-1428.
赵丽娟,刘晓丽,陈芳等.脂质代谢基因表达对子宫内膜癌免疫微环境及预后的影响[J].武汉大学学报(医学版),2025,46(11):1422-1428. DOI: 10.14188/j.1671-8852.2024.0318.
ZHAO Lijuan,LIU Xiaoli,CHEN Fang,et al.Effect of lipid metabolism genes expression on immunemicro environment and prognosis in endometrial carcinoma[J].Medical Journal of Wuhan University,2025,46(11):1422-1428. DOI: 10.14188/j.1671-8852.2024.0318.
目的
2
探讨脂代谢相关基因在子宫内膜癌发生发展和诊断中的作用,为子宫内膜癌的治疗寻找潜在的治疗靶点并基于脂代谢基因并建立预后模型。
方法
2
从癌症基因组图谱(TCGA)的数据库下载子宫内膜癌患者的临床信息和相应的RNA数据,识别与子宫内膜癌患者预后显著相关的脂质代谢相关基因(LMRGs)。采用LASSO和Cox回归分析与子宫内膜癌患者预后显著相关的LMRGs,并基于此构建患者预后模型,进一步建立由LMRGs和临床变量组成的列线图估计子宫内膜癌患者的生存概率。
结果
2
发现ACOT11、CYP1A2、GDPD5、MOGAT3、OLAH、PIASS4、PIP5K1C、PLPP2和SRD5A1与子宫内膜癌患者的临床预后密切相关。由上述9
个LMRGs构建的预测模型能有效区分高低风险患者(
P
<
0.05),并预测子宫内膜癌患者的生存概率。
结论
2
LMRGs基因的表达与子宫内膜癌患者的免疫微环境相关,可用于准确预测子宫内膜癌患者的预后。
Objective
2
To identify the lipid metabolism⁃related genes (LMRGs) in endometrial cancer
explore the role of lipid metabolism in the development and diagnosis of endometrial cancer
find potential therapeutic targets for endometrial cancer treatment
and establish a prognosis model.
Methods
2
Clinical information and corresponding RNA data of endometrial cancer patients were downloaded from the Cancer Genome Atlas (TCGA) database. Subsequently
LMRGs were identified using LASSO and Cox regression analysis to determine those significantly associated with patient prognosis. Based on these analyses
a model was developed to predict patient prognosis. Additionally
a nomogram incorporating risk models and clinical variables was constructed to estimate the survival probability in endometrial cancer patients.
Results
2
Nine LMRGs
ACOT11
CYP1A2
GDPD5
MOGAT3
OLAH
PIASS4
PIP5K1C
PLPP2
and SRD5A1 were found to be closely associated with the clinical prognosis of endometrial cancer patients. The prediction model constructed by the above 9 LMRGs can effectively distinguish high‑risk patients from low‑risk patients (
P
<
0.05)
and predict the survival probability of endometrial cancer patients.
Conclusion
2
The expression levels of LMRGs are associated with the immune microenvironment in endometrial cancer patients and can be utilized to accurately predict their prognosis.
LI X C , YANG X , FAN Y , et al . A ten‑gene methylation signature as a novel biomarker for improving prediction of prognosis and indicating gene targets in endometrial cancer [J ] . Genomics , 2021 , 113 ( 4 ): 2032 ‑ 2044 .
SIEGEL R L , MILLER K D , JEMAL A . Cancer statistics, 2019 [J ] . CA A Cancer J Clinicians , 2019 , 69 ( 1 ): 7 ‑ 34 .
FAN Y , LI X C , TIAN L , et al . Identification of a metabolism‑related signature for the prediction of survival in endometrial cancer patients [J ] . Front Oncol , 2021 , 11 : 630905 .
TALHOUK A , MCCONECHY M K , LEUNG S , et al . Confirmation of ProMisE: A simple, genomics‑based clinical classifier for endometrial cancer [J ] . Cancer , 2017 , 123 ( 5 ): 802 ‑ 813 .
CAO Y H . Adipocyte and lipid metabolism in cancer drug resistance [J ] . J Clin Invest , 2019 , 129 ( 8 ): 3006 ‑ 3017 .
SU P , WANG Q , BI E G , et al . Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor‑associated macrophages [J ] . Cancer Res , 2020 , 80 ( 7 ): 1438 ‑ 1450 .
ZHENG M J , MULLIKIN H , HESTER A , et al . Development and validation of a novel 11‑gene prognostic model for serous ovarian carcinomas based on lipid metabolism expression profile [J ] . Int J Mol Sci , 2020 , 21 ( 23 ): 9169 .
BINNEWIES M , ROBERTS E W , KERSTEN K , et al . Understanding the tumor immune microenvironment (TIME) for effective therapy [J ] . Nat Med , 2018 , 24 ( 5 ): 541 ‑ 550 .
HINSHAW D C , SHEVDE L A . The tumor microenvironment innately modulates cancer progression [J ] . Cancer Res , 2019 , 79 ( 18 ): 4557 ‑ 4566 .
FENG H M , ZHAO Y , YAN W J , et al . Identification of signature genes and characterizations of tumor immune microenvironment and tumor purity in lung adenocarcinoma based on machine learning [J ] . Front Med , 2022 , 9 : 843749 .
ZHONG J T , QIN Y , YU P , et al . The landscape of the tumor‑infiltrating immune cell and prognostic nomogram in colorectal cancer [J ] . Front Genet , 2022 , 13 : 891270 .
BECHT E , GIRALDO N A , LACROIX L , et al . Erratum to: Estimating the population abundance of tissue‑infiltrating immune and stromal cell populations using gene expression [J ] . Genome Biol , 2016 , 17 ( 1 ): 249 .
XUE H Y , XIAO Z Y , ZHAO X J , et al . A comprehensive analysis of immune features and construction of an immune gene diagnostic model for sepsis [J ] . BMC Genomics , 2023 , 24 ( 1 ): 794 .
WANG Y Z , REN F , CHEN P , et al . Identification of a six‑gene signature with prognostic value for patients with endometrial carcinoma [J ] . Cancer Med , 2018 , 7 ( 11 ): 5632 ‑ 5642 .
QIAN H , LEI T , HU Y H , et al . Expression of lipid‑metabolism genes is correlated with immune microenvironment and predicts prognosis in osteosarcoma [J ] . Front Cell Dev Biol , 2021 , 9 : 673827 .
JIANG P P , SUN W , SHEN N M , et al . Identification of a metabolism‑related gene expression prognostic model in endometrial carcinoma patients [J ] . BMC Cancer , 2020 , 20 ( 1 ): 864 .
MAAN M , PETERS J M , DUTTA M , et al . Lipid metabolism and lipophagy in cancer [J ] . Biochem Biophys Res Commun , 2018 , 504 ( 3 ): 582 ‑ 589 .
WAHEED I , ALI A , TABASSUM H , et al . Lipid‑based nanoparticles as drug delivery carriers for cancer therapy [J ] . Front Oncol , 2024 , 14 : 1296091 .
ZALPOOR H , AZIZIYAN F , LIAGHAT M , et al . The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors [J ] . Cell Commun Signal , 2022 , 20 ( 1 ): 186 .
YANG W H , LIU S M , MAO M Y , et al . T‑cell infiltration and its regulatory mechanisms in cancers: Insights at single‑cell resolution [J ] . J Exp Clin Cancer Res , 2024 , 43 ( 1 ): 38 .
QU C H , YAN X , WEI Y J , et al . Establishment and validation of a novel CD8 + T cell‑associated prognostic signature for predicting clinical outcomes and immunotherapy response in hepatocellular carcinoma via integrating single‑cell RNA‑seq and bulk RNA‑seq [J ] . Discov Oncol , 2024 , 15 ( 1 ): 235 .
0
浏览量
17
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621